Call:+1 7755157689
December 1, 2025


Contact Us

Volume 15

Expanding the Role of iTind®: First Clinical Experience in Treating Bladder Neck Contracture Following TURP

1. Abstract 1.1. Background To present the first documented cases of using the iTind® device as a novel, minimally invasive treatment for recurrent bladder neck contracture (BNC) following transurethral resection of the prostate (TURP), and to assess its feasibility, safety, and early outcomes.

Expanding the Role of iTind®: First Clinical Experience in Treating Bladder Neck Contracture Following TURP Read More »

Mapping the Impact of Postoperative Malabsorption on Chronic Wound Healing: A Scoping Review of Evidence Following Gastrointestinal Resection

1. Introduction Chronic wounds are a result of many causes including traumatic, pressure, surgical, and vascular wounds as well as infections, diabetes, medications and nutritional deficiencies [1].

Mapping the Impact of Postoperative Malabsorption on Chronic Wound Healing: A Scoping Review of Evidence Following Gastrointestinal Resection Read More »

Horizontal and Vertical Ridge Augmentation Utilize Allogeneic Bone Block Graft in Anterior and Premolar Area Prior To Implant Placement Follow Up 2 Years

1. Abstract Allografts, derived from donor tissue, are widely utilized in various medical fields, including orthopedics, reconstructive surgery, and organ transplantation.

Horizontal and Vertical Ridge Augmentation Utilize Allogeneic Bone Block Graft in Anterior and Premolar Area Prior To Implant Placement Follow Up 2 Years Read More »

Case Report: Pembrolizumab-Induced Epiglottitis in Early Triple Negative Breast Cancer

https://doi.org/10.47829/ACMCR.2025.15101 The neoadjuvant use of the immune check point inhibitor (ICI) pembrolizumab has significantly increased the complete pathological response (CPR) rate for early triple negative breast cancer (TNBC). However, pembrolizumab is associated with a variety of immune related adverse events (irAEs).

Case Report: Pembrolizumab-Induced Epiglottitis in Early Triple Negative Breast Cancer Read More »

At-Home, Patient-Applied Collagen–Manuka Honey–Hydroxyapatite Dressing for Post- Mohs Surgical Sites: An Eight-Patient Case Series

1. Abstract Non-melanoma skin cancers commonly affect the lower extremities and scalp, where Mohs micrographic surgery (MMS) often leaves wounds with complex healing challenges due to limited vascularity, thin skin, and patient comorbidities. Secondary.

At-Home, Patient-Applied Collagen–Manuka Honey–Hydroxyapatite Dressing for Post- Mohs Surgical Sites: An Eight-Patient Case Series Read More »

Late-onset Cerebrotendinous Xanthomatosis with Mild Symptoms: A Case Report

1. Abstract Cerebrotendinous xanthomatosis (CTX) typically presents with infantile diarrhea, juvenile cataracts, and tendon xanthomas. We report a diagnostically challenging case of late-onset CTX in a 48-year-old male presenting with isolated progressive dys arthria as the sole predominant neurological feature. Notably,

Late-onset Cerebrotendinous Xanthomatosis with Mild Symptoms: A Case Report Read More »

Impact of a Glycine and N-Acetyl Cysteine Ethyl Ester Complex on Antioxidant and Inflammation Status and Related Quality of Life Parameters in Healthy Adult

1. Abstract 1.1. Aim This pilot investigation aimed to assess the impact of a proprietary glycine and N-acetyl cysteine (NAC) ethyl ester complex on quality-of-life (QOL) measures as well as blood levels of antioxidant, inflammatory and toxicant status. Recent evidence.

Impact of a Glycine and N-Acetyl Cysteine Ethyl Ester Complex on Antioxidant and Inflammation Status and Related Quality of Life Parameters in Healthy Adult Read More »

Long-Term Treatment With BRAF/MEK Inhibitors for Pleomorphic Xanthoastro- cytoma Grade 3: A Case Report

1. Abstract 1.1. Background Pleomorphic xanthoastrocytoma grade 3 is rare disease classified as a distinct entity in WHO classification 2016. It is usually refractory to a standard therapy for high grade gliomas and has a dismal prognosis.

Long-Term Treatment With BRAF/MEK Inhibitors for Pleomorphic Xanthoastro- cytoma Grade 3: A Case Report Read More »

You cannot copy content of this page